Pandemic & Heavy Periods: Cochrane Review Interventions
Effective Treatments for Heavy Menstrual Bleeding: What the Evidence Says
Updated June 2, 2025
for women experiencing heavy menstrual bleeding, several treatment options offer relief. A review of multiple studies examined the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs), antifibrinolytics, and combined hormonal contraceptives in managing this common condition.
NSAIDs may provide some benefit compared to a placebo, reducing menstrual blood loss.Though, their effectiveness appears similar to naproxen or combined hormonal contraceptives. Notably, antifibrinolytics seem to outperform NSAIDs in reducing heavy menstrual bleeding.
Antifibrinolytics demonstrate effectiveness against heavy menstrual bleeding when compared to a placebo. Studies suggest they don’t substantially increase the risk of side effects or serious adverse events like thrombotic events. Compared to short-cycle progestogens, antifibrinolytics also appear to be more effective in reducing menstrual blood loss.
Combined hormonal contraceptives show promise in managing heavy menstrual bleeding. Research indicates they are more effective than placebo or no treatment. The incidence of side effects appears similar to that of a placebo.
The review included data from 44 randomized controlled trials involving 3,196 women, ensuring a extensive analysis of available evidence. Limitations in the evidence included risk of bias in the primary RCTs, inconsistency between the primary RCTs, and imprecision in effect estimates.
What’s next
Further research is needed to address limitations and provide more definitive conclusions about the optimal treatments for heavy menstrual bleeding.Future studies should focus on comparing different treatments directly and assessing their long-term effects on women’s health and quality of life.
